chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Moderna Side Effects  Received Vaccine on Tuesday November 2nd, 2021 at approximately 5pm. No immediate side effects . Same day at approximately 9pm I experienced the following side effects: My resting heart rate was between 115-120 bpm. It lasted throughout the night on and off. I also started wheezing and had trouble breathing all night. I also had the mild fever and headach. I have a history of asthma so I got through the trouble breathing by using breathing exercises and remaining calm.  Next day Wednesday November 3rd, 2021. My resting heart rate was 100-105 bpm. Also still had trouble breathing, but kept calm and did the breathing exercises.  Thursday November 4th, 2021. My resting heart rate was at 80-90 bpm. Other side effects were gone as well.
I had the Moderna vaccine (first dose) 8 days ago and for the next two days my arm at the injection site was tender, red and there was a firm lump. Now 8 days later the injection site is still red and blotchy, still a firmness in that area and it itches badly. I'm just concerned since it's been over a week and wonder when it will clear up and if I should get the second dose.
FLU-LIKE SYMPTOMS; HEADACHE; TIREDNESS; FEELING UNWELL; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown, and batch number: UNKNOWN expiry: UNKNOWN) .5 ml, administered on 08-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On MAR-2021, the subject experienced tiredness. On MAR-2021, the subject experienced feeling unwell. On 08-MAR-2021 21:00, the subject experienced flu-like symptoms. On 08-MAR-2021 21:00, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from flu-like symptoms, headache, and tiredness, and the outcome of feeling unwell was not reported. This report was non-serious.
Very swollen lymph nodes in the arm that received vaccination. Started with lymph node in armpit, then worsened with lymph node at the opposite side of the arm from the vaccination and the wrist.
ACUTE NON ST ELEVATION MI 2/1/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Arm sore and then arm bruised from shoulder to elbow over the next couple of days.
1 hour after injection on 2/15/21 - facial numbness and tingling, starting in nose and spreading through face. Symptoms resolved in a couple hours The morning following vaccination 2/16/21 - pain in left arm spreading from injection site down the back of shoulder and arm. Widespread pain in joints. Muscular fatigue. Some relief with NSAIDs. Currently managing at home
5.5 hours after receiving 4 shots (Dtap 2 and IPV 2 on left thigh, and HIB 2 and PCV 2 on right thigh), Mom noted "purplish" discoloration of both legs, from hips to toes. This waxes and wanes. Baby very irritable. No fever. Discoloration lasted for 36 hours.
Patient presented to ED with progressive and worsening SOB 4/27.  Tested positive for COVID-19.  Requiring 60 l/min high flow O2 in ICU at this time.
09/09/22 presents to EC ED for "shortness of breath". PMHx of "atrial fibrillation on warfarin, CAD, ischemic cardiomyopathy with pacemaker in place, CABG x3".
One day post vax, the pt broke out in a fine rash all over the body. No temp or other noticeable discomfort with the rash. An MD visit was recommended.
This case was reported by a other health professional via call center representative and described the occurrence of injection site pain in a adult patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced injection site pain, injection site wheal, injection site erythema and injection site warmth. On an unknown date, the outcome of the injection site pain, injection site wheal, injection site erythema and injection site warmth were unknown. It was unknown if the reporter considered the injection site pain, injection site wheal, injection site erythema and injection site warmth to be related to SHINGRIX. Additional details were reported as follows: The age at vaccination was not applicable for this report. The age group was not reported but was selected as adult as per vaccine indication. The medical assistant reported that, many patients experienced injection area soreness and redness or a welt approximately the size of a quarter after receiving of the SHINGRIX. The purpose of the healthcare professional's call was not to report the adverse events, she mentioned these, as an information, the reporter was asked if she wanted to report any case specifically and she declined, she said many patients have reported more mild reactions. This case has been linked with case US2018GSK161599, reported by the same reporter.
About 3 hours after her second dose, she noticed that her lips were tingling and felt swollen as if she had been to the dentist.  Treated at home with 25mg oral Benadryl.  Cautioned about worsening symptoms and to call 911 if any difficulty breathing or worsening of symptoms.
cold sweats; herpes break out; pain; fatigue; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 06-Apr-2021 and was forwarded to Moderna on 06-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN (pain), HERPES VIRUS INFECTION (herpes break out), COLD SWEAT (cold sweats) and FATIGUE (fatigue) in a 45-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced PAIN (pain) and FATIGUE (fatigue). On 23-Mar-2021, the patient experienced HERPES VIRUS INFECTION (herpes break out). On 03-Apr-2021, the patient experienced COLD SWEAT (cold sweats). The patient was treated with VALACICLOVIR HYDROCHLORIDE (VALTREX) for Herpes infection, at a dose of UNK dosage form. At the time of the report, PAIN (pain), HERPES VIRUS INFECTION (herpes break out), COLD SWEAT (cold sweats) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. Information regarding medical history, concurrent conditions and concomitant medications was not provided.  On 02-JUN-2011, the patient was inoculated with ZOSTAVAX at a clinic as recommended for routine adult health maintenance and for the long-term prevention of shingles. The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster. On or about 30-SEP-2014, the patient was treated at a clinic by a physician for a vesicular outbreak, which was diagnosed as herpes zoster. The patient was prescribed VALTREX, HIBICLENS, mupirocin and clotrimazole topical for management of her painful symptoms. As a direct and proximate result of ZOSTAVAX, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Increase in severity and frequency of head neck and facial tiocs.    Pian at injection site
Within 1 hr, vaccine site sore and swollen. That night headache. Next day migraine, chills, body aches, face flushed. Felt like the flu. Lasted about 24 hours.
Child became dizzy after reaching for object and fell to floor approx 3-4 min after giving immunizations. Child was seated in chair and sugar drink was provided. Child laid down approx 30 min then stated he felt better. Grandmother later stated child had not eaten since breakfast.
She was seen 1/30/2012 for Occ Health screen - she told me she tends to feel lightheaded after blood draws. I gave her 2 vaccines, drew titers & placed a TB skin test - she c/o lightheadedness so she layed down & I elevated her feet - she was better & after a few minutes she went back to work. Today 2/1/2012 she said she started feeling dizzy 2 hrs after visit. She felt feverish that evening & missed work the next day 1/31/2012 feeling dizzy & lightheaded - she also c/o H/A, much of which was resolved today. She only has a slight headache today with no other symptoms. 2/6/2012 - no further effects per patient.
Started with large welts/bumps on my arms. They started itching then within a few hours it turned into hives and welts on my arms, legs, feet, back, stomach.  I went to urgent care that night and they gave me a steroid shot and prescribed me predniSONE. I had relief from itching for about 7 hours, hives were still present. The next morning I woke up with extremely itchy bumps and rashes all over my body. On my face, neck, arms, legs, feet, hands, back, stomach. I went to the doctor again the next morning and they gave me hydrOXYzine and hydrocortisone. By the next day I still had hives present on my face, legs, arm and feet, they were not itchy. I continued to have these for about 3 days. I took my medications for 10 days before it was completely gone.
Severe stomach pain,  nausea and vomiting that has persisted off and on since receiving the vaccine.
Swelling and redness in left leg, above and below knee, with inflammation of knee - painless, began approx. 3 hours after vaccination and symptoms decreasing with time. According to mom, advised family to follow up visit with MD 5/17/03 if symptoms persist, no restrictions on activity upon discharge.
Tinnitus , headache, pressure in head, tightening in forehead, kidney pain with a tightening in cheats. Treated with hearing aids, steroids, and  pain medications.
No Adverse event; administered 13 doses of Moderna COVID-19 Vaccine after more than 30-day use by date.; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered 13 doses of Moderna COVID-19 Vaccine after more than 30-day use by date.) and NO ADVERSE EVENT (No Adverse event) in a 67-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 019H22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 07-Dec-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 07-Dec-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (administered 13 doses of Moderna COVID-19 Vaccine after more than 30-day use by date.). On an unknown date, the patient experienced NO ADVERSE EVENT (No Adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administered 13 doses of Moderna COVID-19 Vaccine after more than 30-day use by date.) and NO ADVERSE EVENT (No Adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No Adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (administered 13 doses of Moderna COVID-19 Vaccine after more than 30-day use by date.).    It was reported patient identifier was patient number 10.  Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Migraine that lasted 10 days, head pain similar to onset of Bells Palsy
2 wk p/vax pt became pregnant. Concomitant tx during pregnancy included levothyroxine sodium (Synthroid).30May97 @38 wk pt delivered female baby (6lb13oz) vaginal delivery.Apgars 1 min - 9/10 & 5min - 9/10.Baby exp feeding problems & monito
Began experiencing dry cough, mild sore throat and fatigue on evening of Thursday, 8/31/2022 Fatigue increased over the next few days to the point of bed rest, tested multiple times with  rapid at-home tests,  tested positive for COVID on morning of Saturday, 09/03/2022.  Continued feeling unusual level of fatigue and fuzzy-headedness for the next five days. Started getting more energy back that increased daily until I finally tested negative on Sunday 09/11/2022. Dry cough diminished over that period until it completely disappeared by Wednesday, 09/14/2022.
In July 2021, 2 months after I was vaccinated my period suddenly started changing. I?ve always been irregular, but never like this. My cramps have been more intense. The most concerning thing is I?ve been on my period for roughly seven days, off of it for roughly seven days, and then back on since the beginning of July. I have never had these problems before.
red at injection sight with large red area above and some below sight, warm to touch, sore at sight
Itching at vaccination site followed by swelling then nausea and SOB - happenned after they left the office so they went to ER - treated with epinephrine, IV Solumedrol and discharged with oral prednisone x5 days.
I was feeling great and went out to nail some boards for a floor in my new shed and got super tired and my muscles started to ache and I got super tired.  I began to hurt all over, especially my breasts. My left breast which has fibrocystic disease hurt much worse. (Earlier in the day I had nailed some boards down with no problem, so I didn't expect any issues the second time.)  I went in the house and decided to soak in the bathtub with some Epsom salt and hot water. That helped some.  I then decided to take Acetaminophen 2-500 mg tablets.  I went to bed early.  I woke up the next morning and still had an issue with my left breast, but my right one was back to normal.  My left breast is still hurting.
Narrative:  COVID infection after completion of COVID vaccine series: 03/17/2021 COVID vaccine dose #1 04/07/2021 COVID vaccine dose #2 07/16/2021 Pt reported experiencing cough and rhinorrhea after having close contact from COVID positive case. Stated needed to get tested to determine if have to reschedule colonoscopy. 07/16/2021 COVID positive per nasopharyngeal swab 07/17/2021 Pt reported onset of chills, fever, fatigue, HA, and myalgia 07/18/2021 Pt reported onset loss of sense of taste/smell 07/20/2021 Pt reported improvement of symptoms to only mild severity 07/20/2021 Clinical resolution of COVID infection per CDC guidelines
non-stop crying since child went home p/shot;redness & sl swelling lt thigh;given DPH elixir;place warm compress @ inj site;
Post menopausal bleeding started occurring 2 days after 2nd dose.; This is a spontaneous report from a contactable consumer (patient). An adult female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Arm Left on 10May2021 11:45 (Batch/Lot Number: EW0167) as 2ND DOSE, SINGLE DOSE for covid-19 immunisation, age at vaccination unknown, at doctor's office. Medical history included breast cancer, high blood pressure from an unknown date and unknown if ongoing. Patient is not pregnant during vaccination. Concomitant medications included tamoxifen; lisinopril; trazodone taken for an unspecified indication, start and stop date were not reported. The patient previously took quinoa. Patient received the first dose BNT162B2 on 19Apr2021 11:30 (lot number EW0164, via left arm) for covid-19 immunisation and experienced Some very light spotting occurred after first dose. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient experienced post menopausal bleeding started occurring 2 days after 2nd dose on 12May2021 16:00 requiring physician office visit. No hospitalization involved.  Some very light spotting occurred after first dose. Patient have not had a period in over a year. Due to taking Tamoxifen for breast cancer diagnosis 4 years ago, I have scheduled an appointment with her OBGyn on 17May2021 to be checked out. Outcome of the event was not recovered. Seriousness criteria reported as non-serious.  No follow-up attempts are needed; information about lot/batch number has been obtained.
cheeks felt hot; dry mouth; Both arm pain; hives where got vaccine; This is a spontaneous report from a non-contactable consumer nurse (patient). A 50-years-old non pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID 19 VACCINE, Formulation: solution for injection, Lot Number Ep7534, Expiration date: not reported) via an unspecified route of administration in Leg Left on 21Mar2021 (age at vaccination 50-years-old) at 09:45 AM as DOSE 1, SINGLE for covid-19 immunization. Medical history included covid-19 on an unknown date (prior vaccination), migraine and had allergies for penicillin from an unknown date and unknown if ongoing. The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient has been tested for COVID-19. Concomitant medications included magnesium, ibuprofen (ADVIL [IBUPROFEN]) and atorvastatin 1 pill taken for an unspecified indication, from an unknown start date. On an unspecified date in Mar2021, the patient experienced both arm pain, hives where the patient got vaccine and Cheeks felt hot, dry mouth on 22Mar2021. On 11May2021, the patient underwent lab test and procedures which included Nasal Swab (Sars-CoV-2 test) was negative. The events was reported as non serious. The outcome of the events was reported as unknown.  No follow-up attempts are possible. No further information is expected.
Outside after dark, the grass under and near the street lamp appeared to be blue/cyan in color. The patient did not notice again until the next day at work when the normally light grey work screen appeared blue/cyan momentarily.; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration in the left arm on 29Apr2021 at 09:30 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure and reported no allergies but reacted to antibiotics in the fluoroquinolone group. The patient had received medication (unspecified) within two weeks of vaccination. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: E0153) via an unspecified route of administration in the left arm on 08Apr2021 at 09:30 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02May2021 at 22:30, the patient experienced while outside after dark, grass under and near the street lamp appeared to be blue/cyan in color. This lasted as long as the patient was outside for about 15 minutes. The patient did not notice again until the next day at work when normally light grey work screen appeared blue/cyan momentarily. It came and went within a few seconds. The clinical outcome of the event grass under and near the street lamp appeared to be blue/cyan in color and screen appeared blue/cyan was unknown at the time of report.   No follow-up attempts are needed. No further information is expected.
Bell's Palsy and signs/symptoms/clinical course characterized by weakness and sensory loss, currently being evaluated by Neurology, most recent clinical note 20Mar2021 states not consistent with Guillian-Barre Syndrome, broad differential diagnosis, high suspicion for medical conditions which mimic acute inflammatory demyelinating polyneuropathy (AIDP).
Call received on 911 at about 6:50 AM 9/18/03. CPR attempted by ambulance personnel. Per mother, child well and without fever when she put child down for evening. Found lying on stomach without response and without breathing at about 6:50 AM by mother. The autopsy report received on 12/17/03 states SIDS.
Continued arm discomfort when lifting or turning my arm. I have not had any treatment. It is only bothersome at night when I sleep and am moving my arm above my head or when I am doing yoga or other exercise where my arm is raised and moving or twisting.
Patient fully vaccinated with two COVID 19 vaccines. Admitted to Hospital on 08/20/2021 with COVID 19. Case expired on 08/31/2021 while still hospitalized.
It started with just a pain in the arm - normal soreness from the injection  site and up the left side of my  neck - but then it spread to the whole upper part of my left arm. It was very , very painful. It wakes me up almost every single night because it hurts. The pain will radiate  - now the pain is more in my arm area and now it's radiating to my back on on the shoulder blade area on the left side - my  neck is a tiny bit sore right. The soreness in the arm is always consistent but the radiating pain moves around somewhat. I am wondering if they gave me the injection incorrectly.  It doesn't seem like it's  what the description of "COVID ARM." I don't have any swelling or redness and I haven't ever.  I take Aleve every now and then. I called the doctor last week and she told me to wait a couple of weeks and watch it.
p/vax pt exp pain, redness, swelling & hot sensation at inj site;
Information has been received from a physician concerning a 7 year old female with no past medical history and no known drug allergies who in October 1998, was vaccinated SC with a 0.5ml dose of varicella virus vaccine (lot # 625382/0309H). Concomitant therapy included famotidine. On 4/13/04 the patient developed breakthrough varicella. She presented to the office on 4/14/04 with breakthrough varicella which was scattered and less than 50 lesions. She had no fever. The physician gave her diphenhydramine hydrochloride and acetaminophen for the itching and discomfort. Unspecified medical attention was sought. There was no product quality complaint. Additional information has been requested.
Pt is 16 years old and was registered in system by mother. Pt came to the clinic with Parent and was administered the Moderna vaccine on 3/19/2021 which is only approved for patients 18 years of age and older.   Reached out to parent and made notification of vaccine administration despite this patient not meeting the age requirement. With guidance provided from Medical Director, parent was informed of next steps.   No adverse reactions reported at this time.
Headache, Myalgia, Arthralgia, Fever, "skin hurts" fatigue Narrative:
This spontaneous report was received from a patient's mother friend referring to a female patient of unknown age. The patient's medical history, concurrent conditions and concomitant medications were not provided. On an unknown date, the patient was vaccinated with a dose of GARDASIL for prophylaxis (dose, route of administration, lot number and expiration date were not provided). On an unknown date, the patient had some reaction in the office after receiving the vaccine, which included her passing out and sweating profusely. The outcome of loss of consciousness and hyperhidrosis is unknown. The reporter considered the events to be related to GARDASIL. The reporter considered the events as medically significant. This is one of two reports received from the same reporter.